Endocyte, Inc. Announces Annual Shareholders' Meeting
WEST LAFAYETTE, Ind., March 23, 2012 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that it will hold its 2012 Annual Meeting of Stockholders on Thurs., May 31, 2012, in Indianapolis.